![Summary from EASL 2021 for Hepatitis B, C, D and fatty liver disease. Liver disease in 2021: advances and remaining challenges. Summary from EASL 2021 for Hepatitis B, C, D and fatty liver disease. Liver disease in 2021: advances and remaining challenges.](https://www.natap.org/2021/images/072521/072521-1/0725212.gif)
Summary from EASL 2021 for Hepatitis B, C, D and fatty liver disease. Liver disease in 2021: advances and remaining challenges.
![Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement - Doyle - 2019 - Medical Journal of Australia - Wiley Online Library Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement - Doyle - 2019 - Medical Journal of Australia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3b15e871-744f-489d-ac07-2b9e5fb27e80/mja2.v210.10.cover.jpg)
Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement - Doyle - 2019 - Medical Journal of Australia - Wiley Online Library
![Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 | MMWR Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 | MMWR](https://www.cdc.gov/mmwr/volumes/72/rr/social-media/rr7201a1_HepatitisB_IMAGE_10Mar2023_1200x675-v2.jpg)
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 | MMWR
![Vaccines | Free Full-Text | Kinetics of Anti-Hepatitis B Surface Antigen Titers in Nurse Students after a Two-Year Follow-Up Vaccines | Free Full-Text | Kinetics of Anti-Hepatitis B Surface Antigen Titers in Nurse Students after a Two-Year Follow-Up](https://www.mdpi.com/vaccines/vaccines-08-00467/article_deploy/html/images/vaccines-08-00467-g001-550.jpg)
Vaccines | Free Full-Text | Kinetics of Anti-Hepatitis B Surface Antigen Titers in Nurse Students after a Two-Year Follow-Up
![Trends in the prevalence of hepatitis B infection among women giving birth in New South Wales | The Medical Journal of Australia Trends in the prevalence of hepatitis B infection among women giving birth in New South Wales | The Medical Journal of Australia](https://www.mja.com.au/sites/default/files/issues/206_07/16.00823.jpg)
Trends in the prevalence of hepatitis B infection among women giving birth in New South Wales | The Medical Journal of Australia
![Modeling Progress Toward Elimination of Hepatitis B in Australia - McCulloch - 2020 - Hepatology - Wiley Online Library Modeling Progress Toward Elimination of Hepatitis B in Australia - McCulloch - 2020 - Hepatology - Wiley Online Library](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/d70c46b5-be2f-4712-a6a4-38765a8392ba/hep30899-fig-0003-m.jpg)
Modeling Progress Toward Elimination of Hepatitis B in Australia - McCulloch - 2020 - Hepatology - Wiley Online Library
![Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study - The Lancet Global Health Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study - The Lancet Global Health](https://www.thelancet.com/cms/attachment/cc9f22a8-521d-4b13-b3d1-236d5739bae5/gr1_lrg.jpg)
Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study - The Lancet Global Health
![Hepatitis B Vaccination Booster Dose After 18 Years Maintains Long-Term Protection - Infectious Disease Advisor Hepatitis B Vaccination Booster Dose After 18 Years Maintains Long-Term Protection - Infectious Disease Advisor](https://www.infectiousdiseaseadvisor.com/wp-content/uploads/sites/16/2019/01/hbvvaccineg6481169481_1280727.jpg)